Global Ankylosing Spondylitis Drug Market Size, Status and Forecast 2024-2031

Report ID: 1012556 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Ankylosing Spondylitis Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Cimzia
        1.2.3 Enbrel
        1.2.4 Humira
        1.2.5 Remicade
        1.2.6 Simponi
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Ankylosing Spondylitis Drug Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Ankylosing Spondylitis Drug Market Perspective (2016-2027)
    2.2 Ankylosing Spondylitis Drug Growth Trends by Regions
        2.2.1 Ankylosing Spondylitis Drug Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Ankylosing Spondylitis Drug Historic Market Share by Regions (2016-2021)
        2.2.3 Ankylosing Spondylitis Drug Forecasted Market Size by Regions (2022-2027)
    2.3 Ankylosing Spondylitis Drug Industry Dynamic
        2.3.1 Ankylosing Spondylitis Drug Market Trends
        2.3.2 Ankylosing Spondylitis Drug Market Drivers
        2.3.3 Ankylosing Spondylitis Drug Market Challenges
        2.3.4 Ankylosing Spondylitis Drug Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Ankylosing Spondylitis Drug Players by Revenue
        3.1.1 Global Top Ankylosing Spondylitis Drug Players by Revenue (2016-2021)
        3.1.2 Global Ankylosing Spondylitis Drug Revenue Market Share by Players (2016-2021)
    3.2 Global Ankylosing Spondylitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Ankylosing Spondylitis Drug Revenue
    3.4 Global Ankylosing Spondylitis Drug Market Concentration Ratio
        3.4.1 Global Ankylosing Spondylitis Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Ankylosing Spondylitis Drug Revenue in 2020
    3.5 Ankylosing Spondylitis Drug Key Players Head office and Area Served
    3.6 Key Players Ankylosing Spondylitis Drug Product Solution and Service
    3.7 Date of Enter into Ankylosing Spondylitis Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Ankylosing Spondylitis Drug Breakdown Data by Type
    4.1 Global Ankylosing Spondylitis Drug Historic Market Size by Type (2016-2021)
    4.2 Global Ankylosing Spondylitis Drug Forecasted Market Size by Type (2022-2027)

5 Ankylosing Spondylitis Drug Breakdown Data by Application
    5.1 Global Ankylosing Spondylitis Drug Historic Market Size by Application (2016-2021)
    5.2 Global Ankylosing Spondylitis Drug Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Ankylosing Spondylitis Drug Market Size (2016-2027)
    6.2 North America Ankylosing Spondylitis Drug Market Size by Type
        6.2.1 North America Ankylosing Spondylitis Drug Market Size by Type (2016-2021)
        6.2.2 North America Ankylosing Spondylitis Drug Market Size by Type (2022-2027)
        6.2.3 North America Ankylosing Spondylitis Drug Market Size by Type (2016-2027)
    6.3 North America Ankylosing Spondylitis Drug Market Size by Application
        6.3.1 North America Ankylosing Spondylitis Drug Market Size by Application (2016-2021)
        6.3.2 North America Ankylosing Spondylitis Drug Market Size by Application (2022-2027)
        6.3.3 North America Ankylosing Spondylitis Drug Market Size by Application (2016-2027)
    6.4 North America Ankylosing Spondylitis Drug Market Size by Country
        6.4.1 North America Ankylosing Spondylitis Drug Market Size by Country (2016-2021)
        6.4.2 North America Ankylosing Spondylitis Drug Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Ankylosing Spondylitis Drug Market Size (2016-2027)
    7.2 Europe Ankylosing Spondylitis Drug Market Size by Type
        7.2.1 Europe Ankylosing Spondylitis Drug Market Size by Type (2016-2021)
        7.2.2 Europe Ankylosing Spondylitis Drug Market Size by Type (2022-2027)
        7.2.3 Europe Ankylosing Spondylitis Drug Market Size by Type (2016-2027)
    7.3 Europe Ankylosing Spondylitis Drug Market Size by Application
        7.3.1 Europe Ankylosing Spondylitis Drug Market Size by Application (2016-2021)
        7.3.2 Europe Ankylosing Spondylitis Drug Market Size by Application (2022-2027)
        7.3.3 Europe Ankylosing Spondylitis Drug Market Size by Application (2016-2027)
    7.4 Europe Ankylosing Spondylitis Drug Market Size by Country
        7.4.1 Europe Ankylosing Spondylitis Drug Market Size by Country (2016-2021)
        7.4.2 Europe Ankylosing Spondylitis Drug Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Ankylosing Spondylitis Drug Market Size (2016-2027)
    8.2 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type
        8.2.1 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type (2016-2027)
    8.3 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application
        8.3.1 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application (2016-2027)
    8.4 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region
        8.4.1 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Ankylosing Spondylitis Drug Market Size (2016-2027)
    9.2 Latin America Ankylosing Spondylitis Drug Market Size by Type
        9.2.1 Latin America Ankylosing Spondylitis Drug Market Size by Type (2016-2021)
        9.2.2 Latin America Ankylosing Spondylitis Drug Market Size by Type (2022-2027)
        9.2.3 Latin America Ankylosing Spondylitis Drug Market Size by Type (2016-2027)
    9.3 Latin America Ankylosing Spondylitis Drug Market Size by Application
        9.3.1 Latin America Ankylosing Spondylitis Drug Market Size by Application (2016-2021)
        9.3.2 Latin America Ankylosing Spondylitis Drug Market Size by Application (2022-2027)
        9.3.3 Latin America Ankylosing Spondylitis Drug Market Size by Application (2016-2027)
    9.4 Latin America Ankylosing Spondylitis Drug Market Size by Country
        9.4.1 Latin America Ankylosing Spondylitis Drug Market Size by Country (2016-2021)
        9.4.2 Latin America Ankylosing Spondylitis Drug Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Ankylosing Spondylitis Drug Market Size (2016-2027)
    10.2 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type
        10.2.1 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2016-2027)
    10.3 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application
        10.3.1 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2016-2027)
    10.4 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country
        10.4.1 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Details
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Ankylosing Spondylitis Drug Introduction
        11.1.4 Amgen Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
        11.1.5 Amgen Recent Development
    11.2 Wyeth
        11.2.1 Wyeth Company Details
        11.2.2 Wyeth Business Overview
        11.2.3 Wyeth Ankylosing Spondylitis Drug Introduction
        11.2.4 Wyeth Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
        11.2.5 Wyeth Recent Development
    11.3 Takeda
        11.3.1 Takeda Company Details
        11.3.2 Takeda Business Overview
        11.3.3 Takeda Ankylosing Spondylitis Drug Introduction
        11.3.4 Takeda Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
        11.3.5 Takeda Recent Development
    11.4 Centocor
        11.4.1 Centocor Company Details
        11.4.2 Centocor Business Overview
        11.4.3 Centocor Ankylosing Spondylitis Drug Introduction
        11.4.4 Centocor Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
        11.4.5 Centocor Recent Development
    11.5 Schering-Plough
        11.5.1 Schering-Plough Company Details
        11.5.2 Schering-Plough Business Overview
        11.5.3 Schering-Plough Ankylosing Spondylitis Drug Introduction
        11.5.4 Schering-Plough Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
        11.5.5 Schering-Plough Recent Development
    11.6 Mitsubishi Tanabe
        11.6.1 Mitsubishi Tanabe Company Details
        11.6.2 Mitsubishi Tanabe Business Overview
        11.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Introduction
        11.6.4 Mitsubishi Tanabe Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
        11.6.5 Mitsubishi Tanabe Recent Development
    11.7 Abbott
        11.7.1 Abbott Company Details
        11.7.2 Abbott Business Overview
        11.7.3 Abbott Ankylosing Spondylitis Drug Introduction
        11.7.4 Abbott Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
        11.7.5 Abbott Recent Development
    11.8 Eisai
        11.8.1 Eisai Company Details
        11.8.2 Eisai Business Overview
        11.8.3 Eisai Ankylosing Spondylitis Drug Introduction
        11.8.4 Eisai Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
        11.8.5 Eisai Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Details
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Ankylosing Spondylitis Drug Introduction
        11.9.4 Pfizer Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
        11.9.5 Pfizer Recent Development
    11.10 Johnson & Johnson
        11.10.1 Johnson & Johnson Company Details
        11.10.2 Johnson & Johnson Business Overview
        11.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Introduction
        11.10.4 Johnson & Johnson Revenue in Ankylosing Spondylitis Drug Business (2016-2021)
        11.10.5 Johnson & Johnson Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Ankylosing Spondylitis Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Cimzia
    Table 3. Key Players of Enbrel
    Table 4. Key Players of Humira
    Table 5. Key Players of Remicade
    Table 6. Key Players of Simponi
    Table 7. Key Players of Others
    Table 8. Global Ankylosing Spondylitis Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Ankylosing Spondylitis Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Ankylosing Spondylitis Drug Market Size by Regions (2016-2021) & (US$ Million)
    Table 11. Global Ankylosing Spondylitis Drug Market Share by Regions (2016-2021)
    Table 12. Global Ankylosing Spondylitis Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 13. Global Ankylosing Spondylitis Drug Market Share by Regions (2022-2027)
    Table 14. Ankylosing Spondylitis Drug Market Trends
    Table 15. Ankylosing Spondylitis Drug Market Drivers
    Table 16. Ankylosing Spondylitis Drug Market Challenges
    Table 17. Ankylosing Spondylitis Drug Market Restraints
    Table 18. Global Ankylosing Spondylitis Drug Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Ankylosing Spondylitis Drug Market Share by Players (2016-2021)
    Table 20. Global Top Ankylosing Spondylitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ankylosing Spondylitis Drug as of 2020)
    Table 21. Ranking of Global Top Ankylosing Spondylitis Drug Companies by Revenue (US$ Million) in 2020
    Table 22. Global 5 Largest Players Market Share by Ankylosing Spondylitis Drug Revenue (CR5 and HHI) & (2016-2021)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Ankylosing Spondylitis Drug Product Solution and Service
    Table 25. Date of Enter into Ankylosing Spondylitis Drug Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
    Table 28. Global Ankylosing Spondylitis Drug Revenue Market Share by Type (2016-2021)
    Table 29. Global Ankylosing Spondylitis Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 30. Global Ankylosing Spondylitis Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 31. Global Ankylosing Spondylitis Drug Market Size Share by Application (2016-2021) & (US$ Million)
    Table 32. Global Ankylosing Spondylitis Drug Revenue Market Share by Application (2016-2021)
    Table 33. Global Ankylosing Spondylitis Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 34. Global Ankylosing Spondylitis Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 35. North America Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
    Table 36. North America Ankylosing Spondylitis Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 37. North America Ankylosing Spondylitis Drug Market Size by Application (2016-2021) (US$ Million)
    Table 38. North America Ankylosing Spondylitis Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 39. North America Ankylosing Spondylitis Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 40. North America Ankylosing Spondylitis Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 41. Europe Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
    Table 42. Europe Ankylosing Spondylitis Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Europe Ankylosing Spondylitis Drug Market Size by Application (2016-2021) (US$ Million)
    Table 44. Europe Ankylosing Spondylitis Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 45. Europe Ankylosing Spondylitis Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 46. Europe Ankylosing Spondylitis Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 47. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region (2016-2021) & (US$ Million) 
    Table 52. Asia-Pacific Ankylosing Spondylitis Drug Market Size by Region (2022-2027) & (US$ Million) 
    Table 53. Latin America Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
    Table 54. Latin America Ankylosing Spondylitis Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Latin America Ankylosing Spondylitis Drug Market Size by Application (2016-2021) (US$ Million)
    Table 56. Latin America Ankylosing Spondylitis Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 57. Latin America Ankylosing Spondylitis Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 58. Latin America Ankylosing Spondylitis Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 59. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 64. Middle East & Africa Ankylosing Spondylitis Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 65. Amgen Company Details
    Table 66. Amgen Business Overview
    Table 67. Amgen Ankylosing Spondylitis Drug Product
    Table 68. Amgen Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
    Table 69. Amgen Recent Development
    Table 70. Wyeth Company Details
    Table 71. Wyeth Business Overview
    Table 72. Wyeth Ankylosing Spondylitis Drug Product
    Table 73. Wyeth Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
    Table 74. Wyeth Recent Development
    Table 75. Takeda Company Details
    Table 76. Takeda Business Overview
    Table 77. Takeda Ankylosing Spondylitis Drug Product
    Table 78. Takeda Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
    Table 79. Takeda Recent Development
    Table 80. Centocor Company Details
    Table 81. Centocor Business Overview
    Table 82. Centocor Ankylosing Spondylitis Drug Product
    Table 83. Centocor Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
    Table 84. Centocor Recent Development
    Table 85. Schering-Plough Company Details
    Table 86. Schering-Plough Business Overview
    Table 87. Schering-Plough Ankylosing Spondylitis Drug Product
    Table 88. Schering-Plough Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
    Table 89. Schering-Plough Recent Development
    Table 90. Mitsubishi Tanabe Company Details
    Table 91. Mitsubishi Tanabe Business Overview
    Table 92. Mitsubishi Tanabe Ankylosing Spondylitis Drug Product
    Table 93. Mitsubishi Tanabe Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
    Table 94. Mitsubishi Tanabe Recent Development
    Table 95. Abbott Company Details
    Table 96. Abbott Business Overview
    Table 97. Abbott Ankylosing Spondylitis Drug Product
    Table 98. Abbott Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
    Table 99. Abbott Recent Development
    Table 100. Eisai Company Details
    Table 101. Eisai Business Overview
    Table 102. Eisai Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
    Table 103. Eisai Recent Development
    Table 104. Pfizer Company Details
    Table 105. Pfizer Business Overview
    Table 106. Pfizer Ankylosing Spondylitis Drug Product
    Table 107. Pfizer Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
    Table 108. Pfizer Recent Development
    Table 109. Johnson & Johnson Company Details
    Table 110. Johnson & Johnson Business Overview
    Table 111. Johnson & Johnson Ankylosing Spondylitis Drug Product
    Table 112. Johnson & Johnson Revenue in Ankylosing Spondylitis Drug Business (2016-2021) & (US$ Million)
    Table 113. Johnson & Johnson Recent Development
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Ankylosing Spondylitis Drug Market Share by Type: 2020 VS 2027
    Figure 2. Cimzia Features
    Figure 3. Enbrel Features
    Figure 4. Humira Features
    Figure 5. Remicade Features
    Figure 6. Simponi Features
    Figure 7. Others Features
    Figure 8. Global Ankylosing Spondylitis Drug Market Share by Application: 2020 VS 2027
    Figure 9. Hospitals Case Studies
    Figure 10. Clinics Case Studies
    Figure 11. Ankylosing Spondylitis Drug Report Years Considered
    Figure 12. Global Ankylosing Spondylitis Drug Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Ankylosing Spondylitis Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Ankylosing Spondylitis Drug Market Share by Regions: 2020 VS 2027
    Figure 15. Global Ankylosing Spondylitis Drug Market Share by Regions (2022-2027)
    Figure 16. Global Ankylosing Spondylitis Drug Market Share by Players in 2020
    Figure 17. Global Top Ankylosing Spondylitis Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ankylosing Spondylitis Drug as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Ankylosing Spondylitis Drug Revenue in 2020
    Figure 19. Global Ankylosing Spondylitis Drug Revenue Market Share by Type (2016-2021)
    Figure 20. Global Ankylosing Spondylitis Drug Revenue Market Share by Type (2022-2027)
    Figure 21. North America Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Ankylosing Spondylitis Drug Market Share by Type (2016-2027)
    Figure 23. North America Ankylosing Spondylitis Drug Market Share by Application (2016-2027)
    Figure 24. North America Ankylosing Spondylitis Drug Market Share by Country (2016-2027)
    Figure 25. United States Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Ankylosing Spondylitis Drug Market Share by Type (2016-2027)
    Figure 29. Europe Ankylosing Spondylitis Drug Market Share by Application (2016-2027)
    Figure 30. Europe Ankylosing Spondylitis Drug Market Share by Country (2016-2027)
    Figure 31. Germany Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Ankylosing Spondylitis Drug Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Ankylosing Spondylitis Drug Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Ankylosing Spondylitis Drug Market Share by Region (2016-2027)
    Figure 41. China Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Ankylosing Spondylitis Drug Market Share by Type (2016-2027)
    Figure 49. Latin America Ankylosing Spondylitis Drug Market Share by Application (2016-2027)
    Figure 50. Latin America Ankylosing Spondylitis Drug Market Share by Country (2016-2027)
    Figure 51. Mexico Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Ankylosing Spondylitis Drug Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Ankylosing Spondylitis Drug Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Ankylosing Spondylitis Drug Market Share by Country (2016-2027)
    Figure 57. Turkey Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Ankylosing Spondylitis Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Amgen Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
    Figure 61. Wyeth Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
    Figure 62. Takeda Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
    Figure 63. Centocor Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
    Figure 64. Schering-Plough Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
    Figure 65. Mitsubishi Tanabe Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
    Figure 66. Abbott Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
    Figure 67. Eisai Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
    Figure 68. Pfizer Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
    Figure 69. Johnson & Johnson Revenue Growth Rate in Ankylosing Spondylitis Drug Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Wyeth
Takeda
Centocor
Schering-Plough
Mitsubishi Tanabe
Abbott
Eisai
Pfizer
Johnson & Johnson
Frequently Asked Questions
Ankylosing Spondylitis Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ankylosing Spondylitis Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ankylosing Spondylitis Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports